Advertisement
ALC vs COO
Which Stock Would AI Choose? Alcon Inc. (ALC) vs. The Cooper Companies, Inc. (COO) Stock Comparison
Key Takeaways
- Alcon Inc. (ALC) and The Cooper Companies, Inc. (COO) both operate in the eye care and medical devices sector, with ALC focused on surgical and vision care products and COO emphasizing contact lenses via CooperVision alongside women's health through CooperSurgical.
- Recent market activity shows both stocks trading in a range-bound pattern amid broader healthcare sector volatility, with ALC demonstrating relatively steadier price behavior compared to COO over recent weeks.
- ALC benefits from its established global scale in ophthalmology, while COO's performance has been influenced by segment-specific demand in vision correction and fertility products.
- Valuation metrics and analyst coverage reflect moderate upside potential for both, though relative momentum favors consistency in ALC's positioning based on observable trends.
- Sector exposure to aging demographics and elective procedures provides common tailwinds, but differences in product diversification create distinct risk profiles.
- Market sentiment remains neutral-to-cautious for the pair, with no major catalysts dominating headlines in the recent period.
Introduction
This comparison examines Alcon Inc. (ALC) and The Cooper Companies, Inc. (COO), two publicly traded companies in the healthcare equipment space with significant overlap in vision care. Investors and traders focused on the medical devices sector may find this analysis relevant for assessing relative positioning, performance differentials, and sector-specific dynamics. The review draws on observable market data, company fundamentals, and recent trading patterns to provide a balanced view suitable for those evaluating portfolio allocations or short-term opportunities within healthcare equities.
ALC Overview and Recent Performance
Alcon Inc. (ALC) is a leading global eye care company offering products in surgical and vision care segments, including intraocular lenses, surgical equipment, and contact lenses. The company maintains a substantial international footprint following its spin-off from Novartis. In recent weeks, ALC shares have exhibited measured price movements within a contained range, supported by steady demand for ophthalmic procedures and consistent operational execution. Broader market activity in healthcare has contributed to sentiment stability, with no outsized volatility tied to company-specific events. Relative performance has shown resilience compared to some peers, reflecting the defensive qualities of its diversified product portfolio amid fluctuating investor risk appetite.
COO Overview and Recent Performance
The Cooper Companies, Inc. (COO) develops and markets contact lenses through its CooperVision segment and medical devices for women's and family health via CooperSurgical. Headquartered in California, the company serves markets worldwide with a focus on specialty lenses and fertility-related products. Recent market activity has seen COO shares experience modest fluctuations influenced by segment demand patterns and overall sector rotation. Performance in recent weeks has aligned with mixed signals in elective medical procedures, resulting in a trading range that mirrors broader healthcare volatility without pronounced directional bias. Sentiment has remained measured, shaped by observable earnings trends and competitive positioning in vision correction.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from hundreds available across the platform. These bots trade thousands of different tickers using varied strategies, timeframes, and risk parameters, with only the most suitable for prevailing market conditions featured in the trending section. Available bots display a range of performance statistics, win rates, and drawdown metrics that allow users to evaluate fit for specific assets like ALC and COO. All bots maintain distinct trading styles and ticker sets, providing options for different investor preferences. Review the full selection on the Trending AI Robots page for detailed statistics and configuration details.
Head-to-Head Comparison
Alcon Inc. (ALC) operates with a primary emphasis on surgical ophthalmology and vision care, offering broader exposure to hospital and clinical settings compared to The Cooper Companies, Inc. (COO), which balances contact lens manufacturing with women’s health products. Growth drivers differ accordingly, with ALC tied more closely to procedural volumes and COO influenced by consumer-driven lens demand alongside fertility services. Recent momentum has favored ALC’s steadier trajectory, while COO has shown greater sensitivity to segment-specific cycles. Risk factors include regulatory and reimbursement pressures common to both, though COO’s diversification may moderate certain exposures. Market sentiment reflects comparable analyst attention, with valuation multiples indicating trade-offs between scale advantages at ALC and niche positioning at COO. Sector exposure to demographics supports both, yet product mix creates clear contrasts in cyclical resilience.
Tickeron AI Verdict
Based on observable factors such as trend consistency and relative stability in recent market activity, Tickeron’s AI would currently assign a modestly higher probabilistic preference to Alcon Inc. (ALC) over The Cooper Companies, Inc. (COO). This reflects ALC’s positioning amid steady sector demand and lower observed volatility, though outcomes remain contingent on evolving catalysts and broader market conditions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a Buy and COO is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 1 FA rating(s) are green whileCOO’s FA Score has 1 green FA rating(s).
- ALC’s FA Score: 1 green, 4 red.
- COO’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 4 TA indicator(s) are bullish while COO’s TA Score has 5 bullish TA indicator(s).
- ALC’s TA Score: 4 bullish, 3 bearish.
- COO’s TA Score: 5 bullish, 4 bearish.
Price Growth
ALC (@Pharmaceuticals: Other) experienced а -1.67% price change this week, while COO (@Pharmaceuticals: Other) price change was -3.45% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.31%. For the same industry, the average monthly price growth was -0.98%, and the average quarterly price growth was -14.76%.
Reported Earning Dates
ALC is expected to report earnings on Aug 10, 2026.
COO is expected to report earnings on Sep 02, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-2.31% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| ALC | COO | ALC / COO | |
| Capitalization | 31.9B | 12.8B | 249% |
| EBITDA | 2.54B | 1.08B | 234% |
| Gain YTD | -17.295 | -20.181 | 86% |
| P/E Ratio | 39.03 | 55.44 | 70% |
| Revenue | 10.6B | 4.15B | 255% |
| Total Cash | 1.66B | 125M | 1,327% |
| Total Debt | 5.25B | 2.5B | 210% |
ALC | COO | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 9 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 18 Undervalued | 72 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 89 | 86 | |
PRICE GROWTH RATING 1..100 | 73 | 59 | |
P/E GROWTH RATING 1..100 | 49 | 14 | |
SEASONALITY SCORE 1..100 | 50 | 46 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALC's Valuation (18) in the Hospital Or Nursing Management industry is somewhat better than the same rating for COO (72) in the Medical Specialties industry. This means that ALC’s stock grew somewhat faster than COO’s over the last 12 months.
ALC's Profit vs Risk Rating (100) in the Hospital Or Nursing Management industry is in the same range as COO (100) in the Medical Specialties industry. This means that ALC’s stock grew similarly to COO’s over the last 12 months.
COO's SMR Rating (86) in the Medical Specialties industry is in the same range as ALC (89) in the Hospital Or Nursing Management industry. This means that COO’s stock grew similarly to ALC’s over the last 12 months.
COO's Price Growth Rating (59) in the Medical Specialties industry is in the same range as ALC (73) in the Hospital Or Nursing Management industry. This means that COO’s stock grew similarly to ALC’s over the last 12 months.
COO's P/E Growth Rating (14) in the Medical Specialties industry is somewhat better than the same rating for ALC (49) in the Hospital Or Nursing Management industry. This means that COO’s stock grew somewhat faster than ALC’s over the last 12 months.
| ALC | COO | |
|---|---|---|
| RSI ODDS (%) | 6 days ago 46% | 2 days ago 60% |
| Stochastic ODDS (%) | 2 days ago 59% | 2 days ago 55% |
| Momentum ODDS (%) | 2 days ago 51% | 2 days ago 62% |
| MACD ODDS (%) | 2 days ago 60% | N/A |
| TrendWeek ODDS (%) | 2 days ago 49% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 50% | 2 days ago 49% |
| Advances ODDS (%) | 2 days ago 58% | 19 days ago 57% |
| Declines ODDS (%) | 8 days ago 56% | 8 days ago 60% |
| BollingerBands ODDS (%) | N/A | 2 days ago 65% |
| Aroon ODDS (%) | 2 days ago 46% | 2 days ago 50% |
Advertisement
COO and
Correlation & Price change
A.I.dvisor indicates that over the last year, COO has been loosely correlated with BDX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then BDX could also see price increases.